[1]
|
Roundtree, I.A., Evans, M.E., Pan, T. and He, C. (2017) Dynamic RNA Modifications in Gene Expression Regulation. Cell, 169, 1187-1200. https://doi.org/10.1016/j.cell.2017.05.045
|
[2]
|
Shi, H., Wei, J. and He, C. (2019) Where, When, and How: Context-Dependent Functions of RNA Methylation Writers, Readers, and Erasers. Molecular Cell, 74, 640-650. https://doi.org/10.1016/j.molcel.2019.04.025
|
[3]
|
Zhou, J., Wan, J., Gao, X., Zhang, X., Jaffrey, S.R. and Qian, S.-B. (2015) Dynamic m6A mRNA methylation directs translational control of heat shock response. Nature, 526, 591-594. https://doi.org/10.1038/nature15377
|
[4]
|
Cai, X., Wang, X., Cao, C., Gao, Y., Zhang, S., Yang, Z., et al. (2018) HBXIP-Elevated Methyltransferase METTL3 Promotes the Progression of Breast Cancer via Inhibiting Tumor Suppressor Let-7g. Cancer Letters, 415, 11-19.
https://doi.org/10.1016/j.canlet.2017.11.018
|
[5]
|
Liu, Y., Wang, R., Zhang, L., Li, J., Lou, K. and Shi, B. (2017) The Lipid Metabolism Gene FTO Influences Breast Cancer Cell Energy Metabolism via the PI3K/AKT Signaling Path-way. Oncology Letters, 13, 4685-4690.
https://doi.org/10.3892/ol.2017.6038
|
[6]
|
Niu, Y., Lin, Z., Wan, A., Chen, H., Liang, H., Sun, L., Wang, Y., et al. (2019) RNA N6-Methyladenosine Demethylase FTO Promotes Breast Tumor Progression through Inhibiting BNIP3. Molecular Cancer, 18, Article No. 46.
https://doi.org/10.1186/s12943-019-1004-4
|
[7]
|
Song, Y., Zheng, C., Tao, Y., Huang, R. and Zhang, Q. (2021) N6-Methyladenosine Regulators Are Involved in the Progression of and Have Clinical Impact on Breast Cancer. Medical science Monitor, 27, Article ID: e929615.
https://doi.org/10.12659/MSM.929615
|
[8]
|
Wang, H., Xu, B. and Shi, J. (2020) N6-Methyladenosine METTL3 Promotes the Breast Cancer Progression via Targeting Bcl-2, Gene, 722, Article ID: 144076. https://doi.org/10.1016/j.gene.2019.144076
|
[9]
|
Wei, M., Bai, J.W., Niu, L., Zhang, Y.Q., Chen, H.Y. and Zhang, G.J. (2020) The Complex Roles and Therapeutic Implications of m6A Modifications in Breast Cancer. Frontiers in Cell and Developmental Biology, 8, Article ID: 615071.
https://doi.org/10.3389/fcell.2020.615071
|
[10]
|
Wu, L., Wu, D., Ning, J., Liu, W. and Zhang, D. (2019) Changes of N6-Methyladenosine Modulators Promote Breast Cancer Progression. BMC Cancer, 19, Article No. 326. https://doi.org/10.1186/s12885-019-5538-z
|
[11]
|
Wu, Y., Wang, Z., Han, L., Guo, Z., Yan, B., Guo, L., et al. (2022) PRMT5 Regulates RNA m6A Demethylation for Doxorubicin Sensitivity in Breast cancer. Molecular Therapy. https://doi.org/10.1016/j.ymthe.2022.03.003
|
[12]
|
Xiong, J., He, J., Zhu, J., Pan, J., Liao, W., Ye, H., et al. (2022) Lactylation-Driven METTL3-Mediated RNA m6A Modification Promotes Immunosuppression of Tumor-Infiltrating Myeloid Cells. Molecular Cell.
https://doi.org/10.1016/j.molcel.2022.02.033
|
[13]
|
Yue, L., Li, L., Liu, F., Hu, N., Zhang, W., Bai, X., et al. (2013) The Oncoprotein HBXIP Activates Transcriptional Coregulatory Protein LMO4 via Sp1 to Promote Proliferation of Breast Cancer Cells. Carcinogenesis, 34, 927-935.
https://doi.org/10.1093/carcin/bgs399
|
[14]
|
Zhang, C., Samanta, D., Lu, H., Bullen, J.W., Zhang, H., Chen, I., et al. (2016) Hypoxia Induces the Breast Cancer Stem Cell Phenotype by HIF-Dependent and ALKBH5-Mediated m6A-Demethylation of NANOG mRNA. Proceedings of the National Academy of Sciences of the United States of America, 113, E2047-E2056.
https://doi.org/10.1073/pnas.1602883113
|
[15]
|
Fu, Y., Dominissini, D., Rechavi, G. and He, C. (2014) Gene Ex-pression Regulation Mediated through Reversible m6A RNA Methylation. Nature Reviews Genetics, 15, 293-306. https://doi.org/10.1038/nrg3724
|
[16]
|
He, C. (2010) Grand Challenge Commentary: RNA Epigenetics? Nature Chemical Biology, 6, 863-865.
https://doi.org/10.1038/nchembio.482
|
[17]
|
Deng, X., Su, R., Feng, X., Wei, M. and Chen, J. (2018) Role of N6-Methyladenosine Modification in Cancer. Current Opinion in Genetics & Development, 48, 1-7. https://doi.org/10.1016/j.gde.2017.10.005
|
[18]
|
Deng, X., Su, R., Weng, H., Huang, H., Li, Z. and Chen, J. (2018) RNA N6-Methyladenosine Modification in Cancers: Current Status and Perspectives. Cell Research, 28, 507-517. https://doi.org/10.1038/s41422-018-0034-6
|
[19]
|
Esteve-Puig, R., Bueno-Costa, A. and Esteller, M. (2020) Writers, Readers and Erasers of RNA Modifications in Cancer. Cancer Letters, 474, 127-137. https://doi.org/10.1016/j.canlet.2020.01.021
|
[20]
|
Panneerdoss, S., Eedunuri, V.K., Yadav, P., Timilsina, S., Raja-manickam, S., et al. (2018) Cross-Talk among Writers, Readers, and Erasers of m6A Regulates Cancer Growth and Pro-gression. Science Advances, 4, Article No. eaar8263.
https://doi.org/10.1126/sciadv.aar8263
|
[21]
|
Chai, R., Chang, Y., Chang, X., Pang, B., An, S., Zhang, K., et al. (2021) YTHDF2 Facilitates UBXN1 mRNA Decay by Recognizing METTL3-Mediated m6A Modification to Activate NF-κB and Promote the Malignant Progression of Glioma. Journal of Hematology & Oncology, 14, Article No. 109. https://doi.org/10.1186/s13045-021-01124-z
|
[22]
|
Liu, J., Yue, Y., Han, D., Wang, X., Fu, Y., Zhang, L., et al. (2014) A METTL3-METTL14 Complex Mediates Mammalian Nuclear RNA N6-Adenosine Methylation. Nature Chemical Biology, 10, 93-95.
https://doi.org/10.1038/nchembio.1432
|
[23]
|
Wang, S., Zou, X., Chen, Y., Cho, W.C. and Zhou, X. (2020) Effect of N6-Methyladenosine Regulators on Progression and Prognosis of Triple-Negative Breast Cancer. Frontiers in Genet-ics, 11, Article ID: 580036.
https://doi.org/10.3389/fgene.2020.580036
|
[24]
|
Huang, T., Cao, L., Feng, N., Xu, B., Dong, Y. and Wang, M. (2021) N6-Methyladenosine (m6A)-Mediated lncRNA DLGAP1-AS1enhances Breast Canceradriamycin Resistance through miR-299-3p/WTAP Feedback Loop. Bioengineered, 12, 10935-10944. https://doi.org/10.1080/21655979.2021.2000198
|
[25]
|
Wang, X., Zhao, B.S., Roundtree, I.A., Lu, Z., Han, D., Ma, H., et al. (2015) N6-Methyladenosine Modulates Messenger RNA Translation Efficiency, Cell, 161, 1388-1399. https://doi.org/10.1016/j.cell.2015.05.014
|
[26]
|
Petri, B.J., Piell, K.M., South Whitt, G.C., Wilt, A.E., Poulton, C.C., Lehman, N.L., et al. (2021) HNRNPA2B1 Regulates Tamoxifen- and Fulvestrant-Sensitivity and Hallmarks of Endo-crine Resistance in Breast Cancer Cells. Cancer Letters, 518, 152-168. https://doi.org/10.1016/j.canlet.2021.07.015
|
[27]
|
Su, R., Dong, L., Li, C., Nachtergaele, S., Wunderlich, M., Qing, Y., et al. (2018) R-2HG Exhibits Anti-Tumor Activity by Targeting FTO/m6A/MYC/CEBPA Signaling. Cell, 172, 90-105.e123. https://doi.org/10.1016/j.cell.2017.11.031
|
[28]
|
Chen, B., Ye, F., Yu, L., Jia, G., Huang, X., Zhang, X., et al. (2012) Development of Cell-Active N6-Methyladenosine RNA Demethylase FTO Inhibitor. Journal of the American Chemical Society, 134, 17963-17971.
https://doi.org/10.1021/ja3064149
|
[29]
|
Yankova, E., Blackaby, W., Albertella, M., Rak, J., De Braekeleer, E., Tsagkogeorga, G., et al. (2021) Small-Molecule Inhibition of METTL3 as a Strategy against Myeloid Leukaemia. Nature, 593, 597-601.
https://doi.org/10.1038/s41586-021-03536-w
|